Diseases Archives - Page 25 of 45 - Pharma Journalist

Eisai asserts positive results of Phase 3 Study for lenvatinib mesylate

Merck KGaA and Pfizer assert Phase III JAVELIN Lung 200 trial results

Tusker Medical enlists first patient for OTTER Study

Servier and ImmunoQure partner to advance human Interferon-α autoantibody

Spineology finishes enrollment in IDE Trial for Mesh Fusion Transplant

FDA concedes Glooko’s Mobile Insulin Dosing System

IRX Therapeutics commences Phase 2 Clinical Trial for CIN3 or VIN3 women

Neurocrine Biosciences files NDA for opicapone for Parkinson’s disease

Sandoz asserts FDA’s approval for initiation of Glatopa

FDA clearance sought for Roche’s Factor II and Factor V test on cobas 4800 system